News | March 26, 2014

Data Show Seno’s Imagio May Eliminate Need for a Breast Biopsy

Two separate analyses of feasibility study data presented at the European Congress of Radiology 2014

March 26, 2014 — Seno Medical Instruments Inc. presented two analyses of outcomes from a U.S. feasibility study of its investigational Imagio breast-imaging device at the annual meeting of the European Congress of Radiology 2014.

The first statistical analysis is of the feasibility study data (Abstract C-0926) and suggests that information from Imagio may have the potential to achieve clinically meaningful sensitivity and specificity for breast cancer beyond those achievable with traditional, standalone diagnostic ultrasound. This will be verified in the ongoing U.S. pivotal study, which has already enrolled more than half of the 2,000 subject target. Imagio may be a useful tool to help physicians reduce the need for breast biopsy in patients with benign but suspicious appearing breast masses on conventional diagnostic breast ultrasound.

The second statistical analysis is of pre-defined histopathology findings relative to the specific features of benign and malignant lesions. This information was captured in the Imagio opto-acoustic images during the feasibility study. It suggests that Imagio may have the potential to provide additional information that could help clinicians grade the aggressiveness of cancerous breast tumors during the imaging phase of a woman's diagnostic work-up, which will also be verified in the ongoing pivotal study.

Separate analysis of the feasibility data showed that OA findings could potentially correlate with molecular subtypes of breast cancer (Abstract C-1528). Imagio fuses an imaging technology based on light-in and sound-out called "opto-acoustics" with traditional ultrasound. The opto-acoustic images provide a unique blood map in and around suspicious breast masses. Unlike other imaging modalities, Imagio doesn't expose patients to potentially harmful ionizing radiation (X-rays) or injectable contrast agents.

For more information: www.SenoMedical.com

Related Content

iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
"Where's My Mammogram?" Campaign Helps Women Own Breast Health Records
News | Breast Imaging | October 10, 2018
October 10, 2018 — Mammosphere launched “Where’s My Mammogram?,” a public service campaign to help women obtain copie
DenseBreast-info.org Launches European Expansion
News | Breast Density | October 10, 2018
DenseBreast-info.org (DB-I) announced the launch of its international expansion for European medical providers. The...
X-ray Mammography Adoption to Skyrocket for Breast Cancer Detection
News | Mammography | October 08, 2018
Highly populated countries have traditionally been slow adopters of non-conventional business models, but a new Frost...
Cullman Regional Medical Center

Cullman Regional Medical Center (Alabama) is a 145-bed medical center serving more than 175,000 residents in a six-county area and recognized as one of the region’s finest medical facilities.

Sponsored Content | Case Study | PACS | October 05, 2018
When Cullman Regional Medical Center in Alabama decided to switch from 2-D
Feature | Mammography | October 05, 2018 | By Jeff Zagoudis
“Patient-centered care” is a popular term among those in the healthcare industry in the 21st century. It means the...
Feature | Breast Imaging | October 04, 2018 | By Tracy Accardi
It has been nearly eight years since the world’s first digital breast tomosynthesis (DBT) mammography technology was...
Leica Biosystems Launches MammoPort Specimen Containment and Transport System
Technology | Breast Biopsy Systems | October 03, 2018
Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system...
Xoft Electronic Brachytherapy System Effective Long-Term for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 02, 2018
Breast cancer recurrence rates for patients treated with the Xoft Axxent Electronic Brachytherapy (eBx) System that...
Survey Shows Dense Breast Reporting Laws Increase Breast Density Awareness
News | Breast Density | October 02, 2018
October 2, 2018 — Results from a new study show that...